Dr Reddys Laboratories (RDY) Gross Margin (2009 - 2026)
Dr Reddys Laboratories (RDY) reported Gross Margin of 46.52% for the quarter ended Jun 30, 2026, down 10.39 percentage points from 56.91% a year earlier but up 1.69 percentage points from the prior quarter.
Dr Reddys Laboratories (RDY) Gross Margin (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Dr Reddys Laboratories' Gross Margin came in at 50.29%, down 7.39 percentage points year-over-year; for the year ended Mar 31, 2026, it was 52.77%, down 5.13 percentage points from the prior year.
- Gross Margin has a five-year change of -1.55 percentage points (years ended Mar 2021 to Mar 2026).
- By year, Gross Margin came in at 57.90% in the year ended Mar 31, 2025 (-0.70 pp), 58.60% in the year ended Mar 31, 2024 (+1.95 pp), 56.65% in the year ended Mar 31, 2023 (+3.57 pp) and 53.08% in the year ended Mar 31, 2022 (-1.24 pp).
- Five-year quarterly Gross Margin spans a low of 44.82% in the quarter ended Mar 31, 2026 and a high of 60.40% in the quarter ended Jun 30, 2024.
- Year over year, Gross Margin has now declined in each of the last six quarters, with an average year-over-year change of -4.56 percentage points over the last eight quarters.
- The high point for year-over-year Gross Margin in five years was the quarter ended Jun 30, 2023 (a gain of 8.83 percentage points); the low point was the quarter ended Mar 31, 2026 (a drop of 10.74 percentage points).
- Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at 44.82% (quarter ended Mar 31, 2026), 53.63% (quarter ended Dec 31, 2025) and 54.67% (quarter ended Sep 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 85.33% |
| 10 | Dr Reddys Laboratories | 10.44 Bn | 9.62 Bn | 396.53 Mn | 46.52% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 46.52% |
| Mar 31, 2026 | 44.82% |
| Dec 31, 2025 | 53.63% |
| Sep 30, 2025 | 54.67% |
| Jun 30, 2025 | 56.91% |
| Mar 31, 2025 | 55.56% |
| Dec 31, 2024 | 58.68% |
| Sep 30, 2024 | 59.59% |
| Jun 30, 2024 | 60.40% |
| Mar 31, 2024 | 58.57% |
| Dec 31, 2023 | 58.50% |
| Sep 30, 2023 | 58.67% |
| Jun 30, 2023 | 58.70% |
| Mar 31, 2023 | 58.69% |
| Dec 31, 2022 | 57.24% |
| Sep 30, 2022 | 59.22% |
| Jun 30, 2022 | 49.86% |
| Mar 31, 2022 | 52.87% |
| Dec 31, 2021 | 52.86% |
| Sep 30, 2021 | 53.78% |
Dr Reddys Laboratories Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();